Skip to main content
Clinical Trials/NCT05395169
NCT05395169UnknownNot Applicable

EFFECT OF DASH DIET AND AEROBIC EXERCISES ON PREMENSTRUAL SYNDROME

Cairo University0 sites50 target enrollmentStarted: June 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
50
Primary Endpoint
Visual analogue scale (VAS)

Study Overview

Brief Summary

Hypothesis:

There will be no effect of the DASH diet and aerobic exercise on premenstrual syndrome.

Statement of the problem:

Do the DASH diet and aerobic exercise have an effect on premenstrual syndrome?

Detailed Description

For some women, symptoms of PMS may be so severe that they miss work or school. Physical activity is a suitable method for the treatment of PMS and is the best method for all women to reduce pressure and balance the brain's chemical secretion. It seems that physical activity by increasing endorphins and reducing adrenal cortisol leads to the improvement of symptoms of PMS.

DASH diet has been suggested to play an important role in the development, and treatment of some psychological disorders. For instance, it has been reported that a diet rich in fish, folate, and B-vitamins can alleviate the manifestations of depression. An established association was also shown between the dietary glycemic index (GI) and psychological diseases, depressive disorder, and mental functioning.

Diets containing of "junk foods" (high energy and low nutritional) have been shown to increase the risk of mental illness, but a healthy diet is associated with less depressive symptoms and can improve mood .

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Investigator)

Eligibility Criteria

Ages
15 Years to 25 Years (Child, Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Fifty adolescent females were diagnosed with premenstrual syndrome.
  • Their age will be ranged from 15-to 25 years (3 years post-puberty).
  • Their body mass index (BMI) will range from 18-25.9 kg/m
  • All are of regular menstrual cycles.
  • All of them suffer from moderate and severe PMS.

Exclusion Criteria

  • Any pathologic findings in the pelvic cavity as a polycystic ovarian syndrome, endometriosis, and pelvic inflammatory diseases.
  • Having irregular menstruation.
  • Any metabolic diseases.
  • Any history of gynecological intervention.

Outcomes

Primary Outcomes

Visual analogue scale (VAS)

Time Frame: assessment will be take 12 weeks

Visual analogue scale (VAS): Degrees of menstrual pain will be assessed using a VAS for all participants in both groups (A\&B) before and after treatment, which is a method of representing .participants pain on a 10 cm linear scale. A score of zero mean "a very low degree of pain" and 10 mean "a very high degree of pain"

Menstrual Distress Questionnaire (MDQ)

Time Frame: assessment will be take 12 weeks

Menstrual Distress Questionnaire (MDQ): The subjects decreased activity, lower back pain, tension or anxiety, breast tenderness, and headaches will assess for all participants in both group before and after treatment using Menstrual Distress Questionnaire (MDQ) .Each item will be score on a 5-point likert scale ,with 1 being "no pain at all" follow by "mild pain", "moderate pain", "slightly sever pain" ,and "extremely severe pain.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Eman Mabrouk El-Said Anwer

specialist physical therapist at Al Delangat Hospital

Cairo University

Similar Trials